Inogen, Inc. — Cyborg Score 4/10

Strategic Profile

Inogen differentiates through its portable oxygen concentrator technology (Inogen One and Rove platforms) that liberates patients from stationary tanks and compressed gas systems. The company leverages a multi-channel distribution strategy through patients, prescribers, home medical equipment providers, and direct rental services to expand market reach in the growing homecare respiratory market.

Cyborg Score Rationale

Inogen operates in a niche but growing market segment with strong intellectual property in portable oxygen concentration. However, recent Q4 2025 revenue missed consensus expectations ($82M vs. $88.6M), indicating near-term execution challenges. The micro-cap valuation and analyst sentiment divergence suggest mixed market confidence.

Top Insights

• Inogen reported Q4 2025 preliminary revenue of $82M, below consensus of $88.6M, signaling near-term headwinds
• Recent Aurora CPAP masks launch (January 2026) expands product portfolio beyond oxygen concentrators
• Company maintains direct-to-patient rental model, providing recurring revenue stream and customer relationships
• Micro-cap stock ($300M market cap range) with limited analyst coverage but bullish sentiment from covered analysts

Named Competitors

• Portable Oxygen Systems — Stationary and portable oxygen concentrators for homecare settings
• CPAP and Respiratory Devices — Cloud-connected CPAP machines and respiratory monitoring platforms
• Oxygen Delivery Systems — Liquid oxygen and compressed gas delivery systems

Recent Developments

• (January 2026) Inogen launches Aurora CPAP masks, expanding respiratory product portfolio
• (January 2026) Q4 2025 preliminary revenue reported at $82M, missing analyst consensus of $88.6M
• (November 2025) Q3 2025 results showed consistent revenue growth with bullish analyst ratings

Open the full interactive Inogen, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.